Cough rescheduling
August 13, 2010
THE National Drugs and Poisons
Schedule Committee has resolved
that certain substances in
preparations for treating cough and
cold be rescheduled to S4 for use in
children less than 2 years of age;
S3 for use in children aged 2-6;
and S2 for people above six.
The Record of Reasons for the
NDPSC meeting in Jun says that
the rescheduling will apply to
brompheniramine, carbetapentane,
chlorpheniramine, codeine,
dexchlorpheniramine, pholcodine,
dextromethorphan, dihydrocodeine,
diphenhydramine, doxylamine,
ipecachuanha, pheniramine,
phenylephrine, promethazine,
pseudoephedrine, senega and
triprolidine.
Changes will only apply where
they will not result in less restrictive
scheduling, and won’t apply to
oxymetazoline and xylometazoline
when for nasal spray use, with the
recommendations referred to a
delegate under the new scheduling
arrangements from Jul.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Aug 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Aug 10
